![]() It is therefore necessary to envisage regional integration of animal health and welfare regulations, including the management of veterinary medicines, among ECOWAS member Countries”. Unfortunately, these regulations are insufficiently enforced. Speaking on behalf of the Executive Director of RAHC, Mr SAVADOGO Joseph of ECOWAS, Coordinator of the “Improvement of animal health and control of veterinary medicines” component of the PRAPS 2 regional project, reinforced Mrs FADIGA’s remarks by pointing out that “most countries have legislation and regulations on veterinary medicinal products. ![]() ![]() ![]() 22/11/10 relating to Community procedures for the management of veterinary medicinal products and Directive C/DIR.1/11/10 relating to veterinary pharmacy. To this end, the ECOWAS Commission adopted several texts in November 2010, namely Regulation C/REG. Studies have concluded that it is feasible to harmonise national veterinary pharmaceutical regulations, through establishing a unified framework for marketing authorisations, quality control and the orientation of policies and regulations for veterinary medicines. Her recommendation is fully in line with ECOWAS’s desire to be at the forefront of public health and public protection. We, therefore, need concerted action and a coordinated regional approach to curb this scourge, as most diseases are cross-border in nature”. The three-day meeting will enable resource persons and members of the Regional Veterinary Committee (RVC) from the 15 ECOWAS Member States plus Mauritania and Chad, namely directors of veterinary services and presidents of veterinary associations, to discuss practical arrangements to facilitate the operationalisation of the regional system.įor Mrs FADIGA Haida Diarrassouba, Technical Advisor, who opened the workshop on behalf of the Ivorian Minister for Animal and Fisheries Resources, “the control of veterinary medicines is a vital concern, given the proliferation of counterfeit medicines or medicines of poor quality, the uncontrolled development of informal drug distribution networks and the growth in antibiotic resistance. The unified framework for marketing authorisation for veterinary medicines is not yet effective in all Member States, despite the various efforts undertaken. While the issue has been addressed for years within the UEMOA space, this is not yet the case for the other 7 non-UEMOA member States. Liberalisation of the veterinary medicines sector in the ECOWAS Member States has had sometimes negative consequences and revealed the need for regional intervention to regulate their marketing in the region and guarantee their quality. Organised by the Regional Animal Health Center (RAHC), through the “Improvement of animal health and control of veterinary medicines” component of the Regional Support Project for Pastoralism in the Sahel (PRAPS), Phase 2, funded by the World Bank, the workshop, which will end on Thursday 22 June 2023, should enable ECOWAS member States to agree on an approach leading to a single, harmonised, and centralised system. A regional workshop on the operationalisation of the regional marketing authorisation system for veterinary medicines opened in Abidjan (Côte d’Ivoire) on 20 June 2023. ECOWAS Debates the Thorny Issue of Marketing Authorisation for Veterinary Medicines in the Region 21 Jun, 2023Ībidjan, Côte d’Ivoire, 20 June 2023.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |